Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

[1]  M. Triggiani,et al.  Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria , 2007, European journal of clinical investigation.

[2]  P. Miller.  Guidelines for the diagnosis of osteoporosis: T-scores vs fractures , 2007, Reviews in Endocrine and Metabolic Disorders.

[3]  A. Órfão,et al.  KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. , 2006, Blood.

[4]  T. Lister,et al.  A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy. , 2006, Leukemia research.

[5]  D. Metcalfe,et al.  Elevated Tryptase Levels Are Associated with Greater Bone Density in a Cohort of Patients with Mastocytosis , 2006, International Archives of Allergy and Immunology.

[6]  E. Wardelmann,et al.  Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. , 2005, Gastroenterology.

[7]  P. Lipsky,et al.  Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature. , 2005, The Journal of allergy and clinical immunology.

[8]  A. Órfão,et al.  Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis. , 2004, The Journal of allergy and clinical immunology.

[9]  A. Burden,et al.  A germline mutation in KIT in familial diffuse cutaneous mastocytosis , 2004, Journal of Medical Genetics.

[10]  Cem Akin,et al.  A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. , 2004, Blood.

[11]  A. Órfão,et al.  Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA) , 2004, Cytometry. Part B, Clinical cytometry.

[12]  A. Tefferi,et al.  Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia. , 2003, Leukemia research.

[13]  D. Gilliland,et al.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. , 2003, Blood.

[14]  U. Lass,et al.  One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. , 2003, The American journal of pathology.

[15]  A. Tefferi,et al.  Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study. , 2002, Mayo Clinic proceedings.

[16]  P. Lipsky,et al.  Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. , 2002, Blood.

[17]  U. Jäger,et al.  Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes , 2002, Leukemia & lymphoma.

[18]  P. Valent,et al.  Tryptase a Novel Biochemical Marker of Acute Myeloid Leukemia , 2002, Leukemia & lymphoma.

[19]  R. Valenta,et al.  Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. , 2001, Blood.

[20]  K. Lennert,et al.  Diagnostic criteria and classification of mastocytosis: a consensus proposal. , 2001, Leukemia research.

[21]  P. Valent,et al.  Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. , 2001, Leukemia research.

[22]  P. Valent,et al.  Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. , 2001, Leukemia research.

[23]  P. Valent,et al.  Clinical and Biologic Diversity of Leukemias Occurring in Patients with Mastocytosis , 2000, Leukemia & lymphoma.

[24]  D. Heitjan,et al.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Lennert,et al.  Diagnostic value of immunostaining for tryptase in patients with mastocytosis. , 1998, The American journal of surgical pathology.

[26]  A. Órfão,et al.  Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. , 1998, Blood.

[27]  Laura H. Tang,et al.  Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm , 1996, Nature Genetics.

[28]  Y. Suzuki,et al.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[30]  W. Travis,et al.  Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. , 1991, The American journal of medicine.

[31]  K. Austen,et al.  Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. , 1991, The Journal of investigative dermatology.

[32]  D. Metcalfe,et al.  Classification and diagnosis of mastocytosis: current status. , 1991, The Journal of investigative dermatology.

[33]  E. Bergstralh,et al.  Systemic Mast Cell Disease: ANALYSIS OF 58 CASES AND LITERATURE REVIEW , 1988, Medicine.

[34]  E. Bergstralh,et al.  Significance of systemic mast cell disease with associated hematologic disorders , 1988, Cancer.

[35]  K. Lennert,et al.  Bone marrow findings in systemic mastocytosis. , 1985, Human pathology.

[36]  K. Lennert,et al.  Tissue mast cells in health and disease. , 1985, Pathology, research and practice.

[37]  K. Lennert,et al.  Mast cells and mast cell neoplasia: a review * , 1979, Histopathology.

[38]  F. Sim,et al.  Mastocytosis (Mast Cell Disease) , 2008 .

[39]  Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. Southampton, Bermuda, June 15, 1990. , 1991, The Journal of investigative dermatology.

[40]  W. Travis,et al.  Solid and hematologic malignancies in 60 patients with systemic mast cell disease. , 1989, Archives of pathology & laboratory medicine.